News

European Media Contact

Thomas Schneckenburger
thomas.schneckenburger@molecularpartners.com
Tel: +41 44 755 5728

U.S. Media Contact

Stefan Riley
stefan@tenbridgecommunications.com
Tel: +1 617 461 2442

Press Releases

January 2021

Molecular Partners to Present at Upcoming Healthcare Investor Conferences

December 2020

Molecular Partners Announces New Clinical Data, Immunomodulation Platform Advances, and Virology Portfolio Strategy

December 2020

Molecular Partners to Share Clinical Data and Expanding Portfolio Strategy at Virtual R&D Day on December 17, 2020

View All News >>

In the News

May 2019

Taking a Drug to Market “Is a Marathon, Not a Sprint”

July 2018

Allergan and Molecular Partners release positive Phase III data on AMD drug

July 2018

In two PhIII wins for Allergan/Molecular Partners, wet AMD drug shows non-inferiority to Lucentis

View More In the News >>